QuVa Pharma Inc., a newly formed national platform for sterile compounding pharmacy services, has acquired the assets of Unique Pharmaceuticals Ltd., including its state-of-the-art 503B manufacturing facility. With the acquisition, QuVa Pharma is addressing supply shortage issues that routinely and adversely impact the industry, and securing significant, immediately-available capacity in a second location. QuVa Pharma received a majority equity commitment from Bain Capital Private Equity as part...